Jeremiah Faith

About Jeremiah Faith

Jeremiah Faith, With an exceptional h-index of 47 and a recent h-index of 44 (since 2020), a distinguished researcher at Icahn School of Medicine at Mount Sinai, specializes in the field of Systems Biology, Microbiome, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Microbiota therapeutics for inflammatory bowel disease: the way forward

Gut-associated lymphoid tissue attrition associates with response to anti-α4β7 therapy in ulcerative colitis

A1 PRE-CLINICAL CROHN’S DISEASE MICROBIOME PROMOTES INFLAMMATION IN GNOTOBIOTIC RECIPIENT MICE

Sa1811 ANTIBIOTIC USE AS A RISK FACTOR FOR INFLAMMATORY BOWEL DISEASE ACROSS THE AGES: A POPULATION-BASED COHORT STUDY

VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial

Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study

Species-specific CD4+ T cells enable prediction of mucosal immune phenotypes from microbiota composition

Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease

Jeremiah Faith Information

University

Position

___

Citations(all)

25161

Citations(since 2020)

14011

Cited By

16936

hIndex(all)

47

hIndex(since 2020)

44

i10Index(all)

62

i10Index(since 2020)

60

Email

University Profile Page

Google Scholar

Jeremiah Faith Skills & Research Interests

Systems Biology

Microbiome

Immunology

Top articles of Jeremiah Faith

Microbiota therapeutics for inflammatory bowel disease: the way forward

2024/5/1

A1 PRE-CLINICAL CROHN’S DISEASE MICROBIOME PROMOTES INFLAMMATION IN GNOTOBIOTIC RECIPIENT MICE

Journal of the Canadian Association of Gastroenterology

2024/3

Sa1811 ANTIBIOTIC USE AS A RISK FACTOR FOR INFLAMMATORY BOWEL DISEASE ACROSS THE AGES: A POPULATION-BASED COHORT STUDY

Gastroenterology

2023/5/1

Jeremiah Faith
Jeremiah Faith

H-Index: 33

VE303, a defined bacterial consortium, for prevention of recurrent Clostridioides difficile infection: a randomized clinical trial

Jama

2023/4/25

Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study

Gut

2023/4/1

Jeremiah Faith
Jeremiah Faith

H-Index: 33

Species-specific CD4+ T cells enable prediction of mucosal immune phenotypes from microbiota composition

Proceedings of the National Academy of Sciences

2023/3/21

Seminars in immunology special issue: Nutrition, microbiota and immunity The unexplored microbes in health and disease

2023/3/1

To Fiber or Not to Fiber: The Swinging Pendulum of Fiber Supplementation in Patients with Inflammatory Bowel Disease

2023/2/21

Compositions and methods for treating inflammatory bowel disease

2017/4/11

DOP70 Crohn’s Disease Like Inflammation of The Pouch is a Distinct Type of Pouchitis

Journal of Crohn's and Colitis

2023/2/1

Gut microbiota bacterial strain richness is species specific and limits therapeutic engraftment

2023

2521. VE707, a Defined Live Biotherapeutic Product for Prevention of Infection by Multidrug-Resistant Gram-Negative Bacteria

Open Forum Infectious Diseases

2023/12

Jeremiah Faith
Jeremiah Faith

H-Index: 33

2140. Biological Features of Response to VE303, a Defined Bacterial Consortium, in Patients with Clostridioides difficile Infection (CDI): Results from the Phase 2 CONSORTIUM Study

Open Forum Infectious Diseases

2023/12

Vanni Bucci
Vanni Bucci

H-Index: 20

Jeremiah Faith
Jeremiah Faith

H-Index: 33

Compositions and Methods for Treating Infections of the Gastrointestinal Tract

2023/10/5

The appendix and ulcerative colitis—an unsolved connection

2023/9

Jeremiah Faith
Jeremiah Faith

H-Index: 33

Searching the gut microbiome for neuroprotective commensals in a mouse model of multiple sclerosis

2023/8/4

Alterations in the gut microbiome implicate key taxa and metabolic pathways across inflammatory arthritis phenotypes

Science Translational Medicine

2023/7/26

Selective IgA2 deficiency in a patient with small intestinal Crohn’s disease

The Journal of Clinical Investigation

2023/6/15

Dusan Bogunovic
Dusan Bogunovic

H-Index: 19

Jeremiah Faith
Jeremiah Faith

H-Index: 33

Serum cytokines and autoantibodies to GM-CSF and immune-related colitis in ipilimumab-treated patients with cancer.

2023/6/1

Manishkumar Patel
Manishkumar Patel

H-Index: 6

Jeremiah Faith
Jeremiah Faith

H-Index: 33

See List of Professors in Jeremiah Faith University(Icahn School of Medicine at Mount Sinai)

Co-Authors

academic-engine